Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study

被引:11
|
作者
Kumar, Kanta [1 ,2 ]
Peters, Sarah [3 ]
Barton, Anne [2 ,4 ]
机构
[1] Univ Manchester, Sch Hlth Sci, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Inst Inflammat & Repair, Manchester M13 9PL, Lancs, England
[3] Manchester Ctr Hlth Psychol, Sch Hlth Sci, Manchester M13 9PL, Lancs, England
[4] Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal BRU, Manchester, Lancs, England
关键词
Rheumatoid arthritis; Predictive testing; Patient perspective; PSYCHOLOGICAL IMPACT; SOCIETY; TRIAL; RISK;
D O I
10.1186/s12891-016-1319-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Rheumatoid arthritis (RA) is a long term condition that requires early treatment to control symptoms and improve long-term outcomes. Lack of response to RA treatments is not only a waste of healthcare resources, but also causes disability and distress to patients. Identifying biomarkers predictive of treatment response offers an opportunity to improve clinical decisions about which treatment to recommend in patients and could ultimately lead to better patient outcomes. The aim of this study was to explore the understanding of and factors affecting Rheumatoid Arthritis (RA) patients' decisions around predictive treatment testing. Methods: A qualitative study was conducted with a purposive sample of 16 patients with RA from three major UK cities. Four focus groups explored patient perceptions of the use of biomarker tests to predict response to treatments. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis by three researchers. Results: Data were organised within three interlinking themes: [1] Perceptions of predictive tests and patient preference of tests; [2] Utility of the test to manage expectations; [3] The influence of the disease duration on take up of predictive testing. During consultations for predictive testing, patients felt they would need, first, careful explanations detailing the consequences of untreated RA and delayed treatment response and, second, support to balance the risks of tests, which might be invasive and/or only moderately accurate, with the potential benefits of better management of symptoms. Conclusions: This study provides important insights into predictive testing. Besides supporting clinical decision making, the development of predictive testing in RA is largely supported by patients. Developing strategies which communicate risk information about predictive testing effectively while reducing the psychological burden associated with this information will be essential to maximise uptake.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [21] Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis
    Bywall, Karin Scholin
    Veldwijk, Jorien
    Hansson, Mats G.
    Kihlbom, Ulrik
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (03): : 297 - 305
  • [22] PATIENT PERSPECTIVES ON FOOTWEAR IN RHEUMATOID ARTHRITIS - A PATIENT-LED QUALITATIVE STUDY
    de Souza, S.
    Lempp, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1364 - 1364
  • [23] Patient Preferences for Biologic Treatments in Rheumatoid Arthritis
    Nafees, Beenish
    Lloyd, Andrew
    Gaich, Carol L.
    Birt, Julie
    Hughes, Rodney A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S213 - S213
  • [24] The prognostic and predictive value of angiogenesis in rheumatoid arthritis
    Jung, Ioan
    Gurzu, Simona
    Mezei, Tibor
    VIRCHOWS ARCHIV, 2008, 452 : S120 - S121
  • [25] PERCEPTIONS OF TESTING TO PREDICT FUTURE DEVELOPMENT OF RHEUMATOID ARTHRITIS AMONG THE FIRST-DEGREE RELATIVES OF PEOPLE WITH RHEUMATOID ARTHRITIS: A QUALITATIVE EXPLORATION
    Stack, Rebecca J.
    Falahee, Marie
    Stoffer, Michaela
    Stamm, Tanja
    Simons, Gwenda
    Buckley, Christopher
    Kumar, Kanta
    Hansson, Mats
    Raza, Karim
    RHEUMATOLOGY, 2015, 54 : 110 - 110
  • [26] Tapering Biologic Therapy for Rheumatoid Arthritis: A Qualitative Study of Patient Perspectives
    Suz Jack Chan
    Lisa K. Stamp
    Nicola Liebergreen
    Henry Ndukwe
    Carlo Marra
    Gareth J. Treharne
    The Patient - Patient-Centered Outcomes Research, 2020, 13 : 225 - 234
  • [27] Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study
    Hazlewood, Glen S.
    Loyola-Sanchez, Adalberto
    Bykerk, Vivian
    Hull, Pauline M.
    Marshall, Deborah
    Tram Pham
    Barber, Claire E. H.
    Barnabe, Cheryl
    Sirois, Alexandra
    Pope, Janet
    Schieir, Orit
    Richards, Dawn
    Proulx, Laurie
    Bartlett, Susan J.
    RHEUMATOLOGY, 2022, 61 (02) : 606 - 616
  • [28] Tapering Biologic Therapy for Rheumatoid Arthritis: A Qualitative Study of Patient Perspectives
    Chan, Suz Jack
    Stamp, Lisa K.
    Liebergreen, Nicola
    Ndukwe, Henry
    Marra, Carlo
    Treharne, Gareth J.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (02): : 225 - 234
  • [29] PERCEPTIONS OF RISK AND COMMUNICATION ABOUT THE RISK OF RELATIVES DEVELOPING RHEUMATOID ARTHRITIS: A QUALITATIVE STUDY OF PATIENTS' PERCEPTIONS
    Falahee, Marie
    Simons, Gwenda
    Raza, Karim
    Stack, Rebecca
    RHEUMATOLOGY, 2016, 55 : 106 - 106
  • [30] The predictive value of attributes of pain to classify rheumatoid arthritis
    La Montagna, G
    Baruffo, A
    Tirri, R
    Viaggi, S
    CLINICAL RHEUMATOLOGY, 2000, 19 (04) : 258 - 261